Cagrilintide

Cagrilintide 10mg — a long-acting amylin analogue researched for appetite regulation, satiety and slowed gastric emptying. Works on a different pathway to GLP-1s, making it a powerful research companion to Tirzepatide or Semaglutide. Third-party tested, 99% purity.

Cagrilintide is a synthetic, long-acting analogue of amylin — the hormone the pancreas co-secretes with insulin after eating to signal satiety. It activates amylin and calcitonin receptors in the hindbrain (area postrema) and hypothalamus, the brain regions that govern appetite, to promote lasting satiety, slow gastric emptying and reduce food intake. Because it acts on a pathway independent of GLP-1, it is studied in combination with GLP-1/GIP agonists (the "CagriSema" combination) for a complementary, dual-axis approach to appetite research. Supplied for research use only. 99% purity, third-party tested by Janoshik Analytical.